| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/17/2002 | CN1358732A Antisense oligonucleitde structure and use using serine/threonine kinase AIM-1 gene as target |
| 07/17/2002 | CN1358731A Antisense oligonucleotide structure and use using serine/threonine kinase P[K] gene as target |
| 07/17/2002 | CN1358543A Recombination plasmid and application in disease prevention and control |
| 07/17/2002 | CN1358415A Artificial planted forest, planting tree method and plant planting method |
| 07/17/2002 | CN1087780C Process for the efficient production of 7-ADCA VIA 3-(carboxyethylthio) propionyl-7-ADCA |
| 07/17/2002 | CN1087747C Method for preparing medicine using silkworm produced recombined human thrombocytopoietic factor |
| 07/17/2002 | CN1087746C Method for preparing medicine using silkworm expressed recombined human erythropoietin |
| 07/16/2002 | US6420630 Methods for tissue culturing and transforming elite inbreds of Zea mays L. |
| 07/16/2002 | US6420629 Process of increasing plant growth and yield and modifying cellulose production in plants |
| 07/16/2002 | US6420628 Seed shattering |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420551 Antisense oligonucleotides targeted against human immunodeficiency virus |
| 07/16/2002 | US6420549 Oligonucleotide analogs having modified dimers |
| 07/16/2002 | US6420548 Method for regulating transcription of foreign genes |
| 07/16/2002 | US6420547 Nucleotide sequences for use as tools in plant genetic engineering |
| 07/16/2002 | US6420546 Oligoribonucleotide and ribozyme analogs with terminal 3′—3′ and/or 5′—5′ linkages |
| 07/16/2002 | US6420545 Nucleotide sequences coding polypeptide for use in the treatment of preferential viral diseases |
| 07/16/2002 | US6420543 Nucleotide sequences coding preferential polypeptide for use in the treatment of immunological and cell proliferative defects |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420540 Toxoplasma gondii antigens |
| 07/16/2002 | US6420539 Nucleotide sequences for use as diagnostic tools in detection of viral infections |
| 07/16/2002 | US6420532 Binding to human y2 receptors and expression |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420530 Polymaleic acid polymer or copolymer with acrylic acid, maleic anhydride, ethyl acrylate or vinyl acetate |
| 07/16/2002 | US6420525 Human transcription factor ZGCL-1 |
| 07/16/2002 | US6420524 Gain of function mutations in ATP-dependent transposition proteins |
| 07/16/2002 | US6420380 Hepatitis C inhibitor tri-peptides |
| 07/16/2002 | US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders |
| 07/16/2002 | US6420345 Methods and reagents for inhibiting angiogenesis |
| 07/16/2002 | US6420339 Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| 07/16/2002 | US6420337 Protein isolated from egg whites and yolks of hyperimmunized animals; amino acid sequence seq id no:1 and 6; upregulation of tumor necrosis factor and interleukins-6 and -1beta; downregulation of transforming growth factor-beta |
| 07/16/2002 | US6420336 Purified antiviral protein, peptide or conjugate encoded by amino acid sequence 90% homologous to seq id no: 2; prophy-lactic or therapeutic inhibition of growth of a virus, such as a retrovirus; human immunodeficiency virus, hiv-1 or hiv-2 |
| 07/16/2002 | US6420335 Cancer therapy; angiostatin or endostatin to sensitize tumor endothelial cells to ionizing radiation |
| 07/16/2002 | US6420176 Composition for delivering DNA into antigen presenting cells |
| 07/16/2002 | US6420175 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/16/2002 | US6420172 Method for inducing tumor immunity |
| 07/16/2002 | US6420170 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin |
| 07/16/2002 | US6420163 Genetically engineered cell for use in prevention and treatment of bacterial, viral, fungal and parasitic infections |
| 07/16/2002 | US6420161 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides |
| 07/16/2002 | US6420160 Expression vector for use in immunotherapy and gene therapy |
| 07/16/2002 | US6420159 1-deoxy-D-xylulose-5-phosphate reductoisomerases, and methods of use |
| 07/16/2002 | US6420158 Nuclelotide coding enzymatic polypeptide for use in bioremediation of fossil fuels |
| 07/16/2002 | US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents |
| 07/16/2002 | US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis |
| 07/16/2002 | US6420153 Nucleotide sequences coding enzymatic polypeptides for use in the diagnosis, treatment and prevention of blood disorders and leukemias |
| 07/16/2002 | US6420152 Bacterial enzymatic polypeptide for use in detection of infection |
| 07/16/2002 | US6420151 Used in fermentative preparation of l-amino acids, in particular l-lysine and l-threonine |
| 07/16/2002 | US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/16/2002 | US6420149 Polypeptides |
| 07/16/2002 | US6420144 Replication of nucleotide sequences; obtain nucleotide sequences, incubate with cloning mixture and polymerase, amplify nucleotide sequences, recover nucleotide sequences |
| 07/16/2002 | US6420140 Production of multimeric protein by cell fusion method |
| 07/16/2002 | US6420138 Regulatory sequences for use as tools in genetic engineering |
| 07/16/2002 | US6420137 Nucleotide sequences coding membrane protein for use treating diet defects and eating disorders |
| 07/16/2002 | US6420135 Streptococcus pneumoniae polynucleotides and sequences |
| 07/16/2002 | US6420134 Vaccines for nontypable haemophilus influenzae |
| 07/16/2002 | US6420124 KVLQT1—a long qt syndrome gene |
| 07/16/2002 | US6420120 Use of a polypeptide as cell receptor for adenoviruses |
| 07/16/2002 | US6420118 Monitoring activity of mutant tumor suppressor protein; obtain sample containing mutant peptide, incubate with wild type cell, monitor tumor suppression activity of cells |
| 07/16/2002 | US6420116 Protein for use in the human therapeutics and diagnosis |
| 07/16/2002 | US6420115 Monitoring binding activities of nuleotide sequences; obtain nucleotide sequences, incubate with probes, detect intensity of bound cmplex |
| 07/16/2002 | US6420113 Chimeric polyclonal antibodies |
| 07/16/2002 | US6420111 Multiplex VGID |
| 07/16/2002 | US6420110 Methods and reagents for isolating biologically active peptides |
| 07/16/2002 | US6420108 Computer-aided display for comparative gene expression |
| 07/16/2002 | US6419929 Genetic engineering |
| 07/16/2002 | US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 07/16/2002 | US6419921 DNA-constructs of blood clotting factors and P-Selectin |
| 07/16/2002 | US6419919 Method for the augmentation of gene expression |
| 07/16/2002 | US6419917 Accumulation of eosinophils using polypeptides |
| 07/16/2002 | US6419827 Purification apparatus and method |
| 07/16/2002 | CA2366135A1 New genes containing a dna sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof |
| 07/16/2002 | CA2254647C Chimeric serine proteases |
| 07/16/2002 | CA2239360C G-csf analog compositions and methods |
| 07/16/2002 | CA2236158C Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/16/2002 | CA2193094C The cytoplasmic inhibition of gene expression |
| 07/16/2002 | CA2124580C Method for selecting recombinant microorganisms containing at their surface at least one molecule having enzymatic activity |
| 07/16/2002 | CA2097200C Protein tyrosine kinase |
| 07/16/2002 | CA2095926C Anti-human milk fat globule humanised antibodies |
| 07/16/2002 | CA2090009C Methods for inhibiting rejection of transplanted tissue |
| 07/16/2002 | CA2059242C Coleopteran-active bacillus thuringiensis isolate and a novel gene encoding a coleopteran-active toxin |
| 07/16/2002 | CA2024063C Antibodies directed against nerve growth factor-like peptides |
| 07/16/2002 | CA1341377C Composition and method for acceleration of clot lysis |
| 07/11/2002 | WO2002054083A2 Alpha synuclein aggregation assays |
| 07/11/2002 | WO2002054073A2 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | WO2002054068A1 Method of reusing dna-immobilization substrate |
| 07/11/2002 | WO2002054064A2 Method for screening for progesterone receptor isoform-specific ligands |
| 07/11/2002 | WO2002053779A2 Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate |
| 07/11/2002 | WO2002053778A2 Method for relative quantification of attached nucleic acids |
| 07/11/2002 | WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 07/11/2002 | WO2002053771A2 Detection of pathogenic bacteria |
| 07/11/2002 | WO2002053770A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/11/2002 | WO2002053761A2 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 07/11/2002 | WO2002053760A2 Chimeric cytolytic viruses for cancer treatment |
| 07/11/2002 | WO2002053759A1 Viral vector for gene therapy |
| 07/11/2002 | WO2002053758A2 Method for producing heterologous proteins in a homothallic fungus of the sordariaceae family |
| 07/11/2002 | WO2002053757A1 Hiv-like particles and the use thereof |
| 07/11/2002 | WO2002053756A2 Regulation of human glucosamine-6-phosphate deaminase |
| 07/11/2002 | WO2002053755A2 Regulation of human otu-like cysteine protease |
| 07/11/2002 | WO2002053754A2 Human protease and polynucleotides encoding the same |
| 07/11/2002 | WO2002053753A2 Novel human lipase and polynucleotides encoding the same |